KPMG AG | Swiss Biotech Association
|Date:||April 24, 2023|
|Time:||17:45 – 18:30|
The four dimensions of Switzerland’s contribution to Health Care systems around the world
– guarantor of reliable life sciences supply chains
– promoter of multinational regulatory networks
– supporter of global HC initiatives
– driver of international research programs
At this panel we will discuss with a group of industry representatives, researchers and NGOs how Switzerland contributes to the strengthening of health care systems around the world.
Isabel Mestres, CEO, C/Can · City Cancer Challenge
Lutz Hegemann, President Global Health & Sustainability, Novartis
Peter Droc, Business Head for Lonza’s Drug Product Services Business, Lonza AG
Prof. Kaspar Wyss, Deputy Director, Swiss Tropical and Public Health Institute
KPMG is a leading professional services firm in Switzerland, noted for clear and consistent solutions in audit, tax and advisory. Through its strong regional presence KPMG is close to you, helping you navigate today’s turbulences to find tomorrow’s answers. KPMG’s Life Sciences experts have a deep understanding of the industry to support companies in challenges around cost & efficiency, valuation & financing or regulatory compliance.
Tweets von https://twitter.com/kpmg_ch